๐Levering van Posaconazol(e) 100 mg tabletten voor de ziekenhuisapotheek
Procurement process summary
This process is to purchase Levering van Posaconazol(e) 100 mg tabletten voor de ziekenhuisapotheek.
This contract was awarded by ๐ง๐ช UZ Leuven for an amount of EUR 97,500 to 1 supplier. It was published on 2023-02-24 through selective
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity๐ง๐ช UZ Leuven Buying unitnot reported Publication date2023-02-24 Contest statusnot reported DescriptionHet voorwerp van de opdracht betreft de levering van het geneesmiddel: De levering van posaconazol(e) 100 mg tabletten voor de ziekenhuisapotheekAwards
This award was granted to Accord Healthcare BV by UZ Leuven for an amount of EUR 97,500. The procurement process was conducted through selective for the category of goods. This is award number 1.
| Supplier | Amount | Award number |
|---|---|---|
| ๐ง๐ช Accord Healthcare BV | EUR 97,500 | 1 |
Market context and opportunities
The execution of this contract allows the entity UZ Leuven to fulfill its public service objectives efficiently.
The selective purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberBE_ocds-70d2nz-89314880-eb7f-416a-88f8-e7e20552035c-award-1Publication date2023-02-24Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityselectiveMethod detailspt_competitive_negotiationStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.

